Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

GENZYME CORPORATION

End-of-day quote Nasdaq  -  07:58 2022-10-06 pm EDT
- USD    0.00%
2011Genzyme Corp.gnl : Mipomersen Data Presented at European Atherosclerosis Society Congress
PU
2011Genzyme Corp.gnl : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares
BU
2011Genzyme Corp.gnl : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group
BU
SummaryNewsCompanyFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about GENZYME CORPORATION
2011Genzyme Corp.gnl : Mipomersen Data Presented at European Atherosclerosis Society Congress
PU
2011Genzyme Corp.gnl : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-av..
BU
2011Genzyme Corp.gnl : Genzyme Completes Sale of Pharmaceuticals Business to International Che..
BU
2011Genzyme Corp.gnl : Genzyme Recognizes International Rare Disease Day by Launching New Pati..
BU
2011Genzyme Corp.gnl : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Comp..
BU
2011Genzyme Corp.gnl : Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Y..
BU
2011Genzyme Corp.gnl : Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.
BU
2011Genzyme Corp.gnl : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
BU
2011Genzyme Corp.gnl : Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lum..
BU
2011Genzyme Corp.gnl : Genzyme Financial Recovery Continues in Fourth Quarter
BU
2011Genzyme Corp.gnl : Genzyme Statement on Discussions With Sanofi-Aventis
BU
2010Genzyme Corp.gnl : Genzyme Details Market Potential of Alemtuzumab for MS
BU
2010Genzyme Corp.gnl : Genzyme to Hold Investor Event on Alemtuzumab
BU
2010Genzyme Corp.gnl : Genzyme Reiterates Board's Position on Sanofi-Aventis Tender Offer
BU
2010Genzyme Corp.gnl : Genzyme Completes Sale of Genetic Testing Business to LabCorp
BU
More most relevant news
All news about GENZYME CORPORATION
2011Genzyme Corp.gnl : Mipomersen Data Presented at European Atherosclerosis Society Congress
PU
2011Genzyme Corp.gnl : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-av..
BU
2011Genzyme Corp.gnl : Genzyme Completes Sale of Pharmaceuticals Business to International Che..
BU
2011Genzyme Corp.gnl : Genzyme Recognizes International Rare Disease Day by Launching New Pati..
BU
2011Genzyme Corp.gnl : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Comp..
BU
2011Genzyme Corp.gnl : Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Y..
BU
2011Genzyme Corp.gnl : Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.
BU
2011Genzyme Corp.gnl : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
BU
2011Genzyme Corp.gnl : Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lum..
BU
2011Genzyme Corp.gnl : Genzyme Financial Recovery Continues in Fourth Quarter
BU
More news
News in other languages on GENZYME CORPORATION
2011Genzyme : succès de l'OPE de Sanofi-aventis.
2011Genzyme : Sanofi-aventis modifie son offre.
2011GENZYME CORP.GNL : Résultat trimestriel de Genzyme dans la fourchette a..
2011Genzyme : racheté par Sanofi-Aventis.
2011GENZYME CORP.GNL : bénéfice inférieur aux attentes
2011Genzyme : proche d'un accord avec Sanofi-Aventis ?
2011GENZYME CORP.GNL : a signé un accord de confidentialité avec SANOFI
2011Genzyme : Sanofi-Aventis prolonge son offre publique d'achat.
2011GENZYME CORP.GNL : L'OPA de Sanofi sur Genzyme devrait réussir, selon l..
2011GENZYME CORP.GNL : Les résultats trimestriels de Genzyme décevants, rie..
More news
Press releases
2011Genzyme Corp.gnl : Mipomersen Data Presented at European Atherosclerosis Society Congress
PU
2011Genzyme Corp.gnl : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-av..
BU
2011Genzyme Corp.gnl : Genzyme Completes Sale of Pharmaceuticals Business to International Che..
BU
2011Genzyme Corp.gnl : Genzyme Recognizes International Rare Disease Day by Launching New Pati..
BU
2011Genzyme Corp.gnl : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Comp..
BU
More press releases